• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
Why is GW Pharmaceuticals a Strong Buy?

Why is GW Pharmaceuticals a Strong Buy?

Cannabis in the News, CBD Stocks, Gw Pharmaceuticals, marijuana stock, Medical, Stock Talk

Why is GW Pharmaceuticals a Strong Buy? Cannabis stocks continue to soar after five states in the US legalized marijuana use on Friday, November 6. Stocks like Aurora Cannabis (NYSE: ACB) rose because the announcement acted as a lifeline to the much-troubled company....
Hemp Stocks: Will Charlotte’s Web Make a Comeback in 2021?

Hemp Stocks: Will Charlotte’s Web Make a Comeback in 2021?

Cannabis in the News, CBD in the News, CBD Stocks, Hemp, Investment Opportunities, Medical, Stock Talk

Hemp Stocks: Will Charlotte’s Web Make a Comeback in 2021? While tech stocks invariably attract a significant amount of interest due to their potential to generate market-beating returns, it seems Wall Street has turned a blind eye towards an equally disruptive...
GW Pharmaceuticals: Will this Hemp Stock Continue to Soar in 2020?

GW Pharmaceuticals: Will this Hemp Stock Continue to Soar in 2020?

Cannabis in the News, CBD Stocks, marijuana stock, Medical, Stock Talk

GW Pharmaceuticals: Will this Hemp Stock Continue to Soar in 2020? GW Pharmaceuticals (NASDAQ: GWPH) is one rare hemp stock that has almost doubled since March 2020. With nearly a 10% rally in the past month, GWPH has raised the bar for the medical cannabis sector....
GW Pharmaceuticals – one of the most appealing stocks during the coronavirus pandemic?

GW Pharmaceuticals – one of the most appealing stocks during the coronavirus pandemic?

Cannabis in the News, Hemp, Investment Opportunities, marijuana stock, marijuana stock investment opportunity 2020, Medical, Stock Talk

GW Pharmaceuticals – one of the most appealing stock during the coronavirus pandemic? GW Pharmaceuticals (NASDAQ: GWPH) is a UK-based innovative venture with a solid 20-year track record leveraging the power of cannabinoid therapeutics. GW’s medicines treat...
First of its kind study on effect of topical CBD on NCAA Student-Athletes

First of its kind study on effect of topical CBD on NCAA Student-Athletes

Cannabis in the News, Health, Hemp, Medical

First of its kind study on effect of topical CBD on NCAA Student-Athletes Student-athletes, their parents, as well as the general population, will benefit by understanding how a safe, pure and effective topical CBD lotion can help them get pain relief without opiates...
Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer

Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer

Cannabis in the News, Medical

Cannabics Pharmaceuticals Develops Novel Cannabis Formulation for the Treatment of Colon Cancer TEL AVIV, Israel and BETHESDA, Maryland, April 13, 2020 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine...
« Older Entries

Search Cannabis and Hemp Stocks

Cannin’s Stock Picks

Best Hemp Stocks 2021

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • ScottsMiracle-Gro Announces Record Second Quarter Results
  • Biden Proposes Plan to Pay Hemp Farmers for Carbon
  • What States are Most Likely to Legalize Marijuana in 2021?
  • South Dakota Supreme Court and Amendment A – What’s Next?
  • US House Passes SAFE Banking Act with a Substantial Majority
  • Trulieve: When to Buy or Sell this Cannabis Stock
  • 4 Hot Hemp Stocks to Buy Now
HempFusion TSX CBD Hemp Stocks

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

Cannin Monthly Subscription with Trading Alerts

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 30-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Cannin’s Track Record

Hemp Stocks CBD Stocks Free Stock Tips

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Planet 13 Holdings $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Innovative Industrial Properties $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $99.00 $49.00
  • The Cannin Report 2020 $49.00 $19.00
  • FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick $9.99 $0.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

HempFusion TSX CBD Hemp Stocks

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
Terms:
First Month $1, then $39/month. Cancel Anytime.
First Name Required
Last Name Required
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
Terms:
First Month $1 then $99/month. Cancel Anytime.
First Name Required
Last Name Required
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above